Spilsense

1 stories about Spilsense
ד"ר גילי הרט מנכ"לית ספלייסנס

SpliSense secures $28.5 million in funding to advance mRNA-altering pipeline for treatment of CF

13.05.21|Meir Orbach
The Israeli startup was founded by Prof. Batsheva Kerem, a renowned geneticist from the Hebrew University of Jerusalem, and its technology is based on her research
ProfilesEngineServlet?at=39&mi=10&pt=18&dpi=1243103233&pai=cTech&dpn=4409&mt=1